Seth Klarman’s portfolio: Baupost Group 13F holdings

Quarterly SEC 13F-HR filingsCIK 0001061768Latest: Q2 2026

Q3 2013 filing in brief

In its Q3 2013 13F, filed November 13, 2013, Baupost Group reported $3.5B across 20 US positions. The largest: MU (31.9%), THERAVANCE INC (21.6%), VSAT (20.0%), BP (6.7%), IDENIX PHARMACEUTICALS INC (4.4%). In the quarter it opened 1 position, sold out of 5, added to 4 and trimmed 4; positions opened and sold out came to 15.8% of the portfolio's value.

Methodology

Holdings come from the manager’s Form 13F-HR filings on SEC EDGAR, with amendments applied. Values and shares are reported at quarter-end; the filing date is when the report became public. These disclosures show reported long positions and listed options, not the manager’s entire portfolio or its trades since quarter-end.

Quarterly changes compare shares with the immediately preceding quarter on file. New and exited positions appear or disappear; added and trimmed positions change their share count by more than 1%. A share change can also reflect a stock split or other corporate action.

Opened and sold out is the value of new positions plus the prior value of exited positions, divided by the average of the two quarters’ reported portfolio values. It excludes changes to positions still held. Reported value growth includes price changes and is not a measure of investment performance. Largest-five and largest-ten weights exclude options.

Holdings

Filed Nov 13, 2013

  • 1 New
  • 4 Added
  • 4 Trimmed
  • 5 Exited

20 positions at September 30, 2013. Q/Q change compares shares with the preceding quarter.

RowTickerIssuerStatus
1MUMICRON TECHNOLOGY INC$1.1B64.0M31.95%+54.2%Added
2—THERAVANCE INC$757M18.5M21.62%+11.9%Added
3VSATVIASAT INC$700M11.0M20.01%0.0%Held
4BPBP PLC$235M5.6M6.72%−69.9%Trimmed
5—IDENIX PHARMACEUTICALS INC$154M29.7M4.40%+10.8%Added
6ROVIEURROVI CORP$118M6.2M3.38%0.0%Held
7ORCLORACLE CORP$79M2.4M2.26%0.0%Held
8—CITIGROUP INC$70M94.2M2.01%0.0%Held
9—CHIPMOS TECH BERMUDA LTD$59M3.3M1.69%+18.8%Added
10NGNOVAGOLD RES INC$50M21.7M1.44%0.0%Held
11—SYNERON MEDICAL LTD$34M4.0M0.99%0.0%Held
12PBFPBF ENERGY INC$21M955.1K0.61%—New
13—ALLIANCE ONE INTL INC$19M6.4M0.53%−16.8%Trimmed
14MU 1.875 06/01/27MICRON TECHNOLOGY INC$18M11.4M0.52%0.0%Held
15CPFCENTRAL PAC FINL CORP$14M779.7K0.39%−47.7%Trimmed
16ENZNEURENZON PHARMACEUTICALS INC$13M7.7M0.37%0.0%Held
17—AMERICAN INTL GROUP INC$12M656.4K0.36%0.0%Held
18—NOVACOPPER INC$9M5.0M0.27%0.0%Held
19—ITURAN LOCATION AND CONTROL$9M476.3K0.25%−54.1%Trimmed
20AVEOEURAVEO PHARMACEUTICALS INC$8M3.8M0.23%0.0%Held
5 exited positions

Positions held in the preceding quarter and absent from this filing. Values and shares are from the preceding quarter.

TickerIssuerPrevious valuePrevious shares
AIGAMERICAN INTL GROUP INC$452M10.1M
INVA 3 01/15/15THERAVANCE INC$79M51.0M
YRIYAMANA GOLD INC$31M3.3M
KGCKINROSS GOLD CORP$11M2.1M
PVG1EURPRETIUM RES INC$1M155.7K
Every quarter on file (53)

From the manager’s Form 13F-HR filings on SEC EDGAR, amendments applied. Long US positions only; not a recommendation.